AI and biomarkers join forces to spot sepsis in kids faster
NCT ID NCT05311046
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will test a new AI-powered screening tool that uses biomarker data to help doctors recognize sepsis earlier in children arriving at the emergency room. Over 12,000 participants, including children with suspected sepsis and controls, will be enrolled. The goal is to improve early detection and enable more personalized treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could provide a faster, more accurate way to spot sepsis in children, leading to earlier treatment and better outcomes.
- What could go wrong
- The trial hasn't started yet, and the tool's performance in real-world ER settings is unproven. It may not work as well across different hospitals or patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's National Hospital
Washington D.C., District of Columbia, 20010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we optimize antibiotic dosing for children with sepsis?
- Could starting feeds sooner shield preterm babies from infection?
- Can brain waves predict thinking problems after sepsis?
- Can tailored nutrition boost recovery in the ICU?
- Blood markers may foretell brain fog after sepsis
- A hidden clue in the fingertips: could a pulse oximeter reading forecast sepsis outcomes?